KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Invested Capital (2017 - 2025)

Sarepta Therapeutics has reported Return on Invested Capital over the past 9 years, most recently at 0.01% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 1.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.01%, down 1.0%, while the annual FY2025 figure was 0.0%, 1.0% down from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.01% at Sarepta Therapeutics, down from 0.0% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.0% in Q4 2024 and troughed at 0.01% in Q4 2025.
  • A 5-year average of 0.0% and a median of 0.0% in 2022 define the central range for Return on Invested Capital.
  • Biggest five-year swings in Return on Invested Capital: changed 0bps in 2021 and later fell -1bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.0% in 2021, then increased by 23bps to 0.0% in 2022, then skyrocketed by 51bps to 0.0% in 2023, then skyrocketed by 155bps to 0.0% in 2024, then plummeted by -947bps to 0.01% in 2025.
  • Business Quant data shows Return on Invested Capital for SRPT at 0.01% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.